Research Article

IL-6 Promotes the Proliferation and Immunosuppressive Function of Myeloid-Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer

Figure 1

Interleukin 6 (IL-6) levels increased in muscle-invasive bladder cancer (MIBC) and promoted cancer progression. (a) IL-6 levels in MIBC tissues and normal urothelium determined by the enzyme-linked immunosorbent assay (ELISA). (b) Immunochemistry results for IL-6 in MIBC tissues and normal urothelium. (c) IL-6 levels in MIBC tissues and recurrent MIBC determined by ELISA. (d) Immunochemistry results for IL-6 in MIBC tissues and recurrent MIBC. (e) Prognosis of patients with high or low IL-6 expression according to TCGA database. (f) MIBC tumor volume with or without IL-6 treatment (). (g) Tumor weight with or without IL-6 treatment (). (h) Survival time for mice with MIBC with or without IL-6 treatment (). , , , and .
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)